 | • レポートコード：MRC2-11QY12534 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は長時間作用型注射剤（LAI）のグローバル市場について調査・分析したレポートです。種類別（第一世代、第二世代）市場規模、用途別（統合失調症、避妊、HIV、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別長時間作用型注射剤（LAI）の競争状況、市場シェア ・世界の長時間作用型注射剤（LAI）市場：種類別市場規模 2015年-2020年（第一世代、第二世代） ・世界の長時間作用型注射剤（LAI）市場：種類別市場規模予測 2021年-2026年（第一世代、第二世代） ・世界の長時間作用型注射剤（LAI）市場：用途別市場規模 2015年-2020年（統合失調症、避妊、HIV、その他） ・世界の長時間作用型注射剤（LAI）市場：用途別市場規模予測 2021年-2026年（統合失調症、避妊、HIV、その他） ・北米の長時間作用型注射剤（LAI）市場分析：米国、カナダ ・ヨーロッパの長時間作用型注射剤（LAI）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの長時間作用型注射剤（LAI）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の長時間作用型注射剤（LAI）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの長時間作用型注射剤（LAI）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Alkermes、Johnson & Johnson、Zogenix、DURECT、Mapi Pharma、GSK、MedinCell、Oakwood Labs、Nanomi、Pharmathen、Kashiv BioSciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.
Market Analysis and Insights: Global Long-acting Injectable Medications Market
The global Long-acting Injectable Medications market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long-acting Injectable Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long-acting Injectable Medications market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long-acting Injectable Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long-acting Injectable Medications market.
Global Long-acting Injectable Medications Scope and Segment
Long-acting Injectable Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long-acting Injectable Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
First-generation
Second-generation
Market segment by Application, split into
Schizophrenia
Contraception
HIV
Others
Based on regional and country-level analysis, the Long-acting Injectable Medications market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
In the competitive analysis section of the report, leading as well as prominent players of the global Long-acting Injectable Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 First-generation
1.3.3 Second-generation
1.4 Market by Application
1.4.1 Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2026
1.4.2 Schizophrenia
1.4.3 Contraception
1.4.4 HIV
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-acting Injectable Medications Market Perspective (2015-2026)
2.2 Long-acting Injectable Medications Growth Trends by Regions
2.2.1 Long-acting Injectable Medications Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Long-acting Injectable Medications Historic Market Share by Regions (2015-2020)
2.2.3 Long-acting Injectable Medications Forecasted Market Size by Regions (2021-2026)
2.3 Long-acting Injectable Medications Industry Dynamic
2.3.1 Long-acting Injectable Medications Market Trends
2.3.2 Long-acting Injectable Medications Market Drivers
2.3.3 Long-acting Injectable Medications Market Challenges
2.3.4 Long-acting Injectable Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-acting Injectable Medications Players by Market Size
3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2015-2020)
3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2015-2020)
3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue
3.4 Global Long-acting Injectable Medications Market Concentration Ratio
3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2019
3.5 Key Players Long-acting Injectable Medications Area Served
3.6 Key Players Long-acting Injectable Medications Product Solution and Service
3.7 Date of Enter into Long-acting Injectable Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-acting Injectable Medications Breakdown Data by Type
4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2015-2020)
4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026)
5 Long-acting Injectable Medications Breakdown Data by Application
5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2015-2020)
5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Long-acting Injectable Medications Market Size (2015-2026)
6.2 North America Long-acting Injectable Medications Market Size by Type (2015-2020)
6.3 North America Long-acting Injectable Medications Market Size by Application (2015-2020)
6.4 North America Long-acting Injectable Medications Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Long-acting Injectable Medications Market Size (2015-2026)
7.2 Europe Long-acting Injectable Medications Market Size by Type (2015-2020)
7.3 Europe Long-acting Injectable Medications Market Size by Application (2015-2020)
7.4 Europe Long-acting Injectable Medications Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2015-2026)
8.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2015-2020)
8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2015-2020)
8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Long-acting Injectable Medications Market Size (2015-2026)
9.2 Latin America Long-acting Injectable Medications Market Size by Type (2015-2020)
9.3 Latin America Long-acting Injectable Medications Market Size by Application (2015-2020)
9.4 Latin America Long-acting Injectable Medications Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2015-2026)
10.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2015-2020)
10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2015-2020)
10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2015-2020))
11.1.5 Eli Lilly Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Details
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Long-acting Injectable Medications Introduction
11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2015-2020)
11.2.5 Alkermes Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2015-2020)
11.3.5 Johnson & Johnson Recent Development
11.4 Zogenix
11.4.1 Zogenix Company Details
11.4.2 Zogenix Business Overview
11.4.3 Zogenix Long-acting Injectable Medications Introduction
11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2015-2020)
11.4.5 Zogenix Recent Development
11.5 DURECT
11.5.1 DURECT Company Details
11.5.2 DURECT Business Overview
11.5.3 DURECT Long-acting Injectable Medications Introduction
11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2015-2020)
11.5.5 DURECT Recent Development
11.6 Mapi Pharma
11.6.1 Mapi Pharma Company Details
11.6.2 Mapi Pharma Business Overview
11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2015-2020)
11.6.5 Mapi Pharma Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Long-acting Injectable Medications Introduction
11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2015-2020)
11.7.5 GSK Recent Development
11.8 MedinCell
11.8.1 MedinCell Company Details
11.8.2 MedinCell Business Overview
11.8.3 MedinCell Long-acting Injectable Medications Introduction
11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2015-2020)
11.8.5 MedinCell Recent Development
11.9 Oakwood Labs
11.9.1 Oakwood Labs Company Details
11.9.2 Oakwood Labs Business Overview
11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2015-2020)
11.9.5 Oakwood Labs Recent Development
11.10 Nanomi
11.10.1 Nanomi Company Details
11.10.2 Nanomi Business Overview
11.10.3 Nanomi Long-acting Injectable Medications Introduction
11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2015-2020)
11.10.5 Nanomi Recent Development
11.11 Pharmathen
10.11.1 Pharmathen Company Details
10.11.2 Pharmathen Business Overview
10.11.3 Pharmathen Long-acting Injectable Medications Introduction
10.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2015-2020)
10.11.5 Pharmathen Recent Development
11.12 Kashiv BioSciences
10.12.1 Kashiv BioSciences Company Details
10.12.2 Kashiv BioSciences Business Overview
10.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
10.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2015-2020)
10.12.5 Kashiv BioSciences Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Long-acting Injectable Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of First-generation
Table 3. Key Players of Second-generation
Table 4. Global Long-acting Injectable Medications Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Long-acting Injectable Medications Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Long-acting Injectable Medications Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Long-acting Injectable Medications Market Share by Regions (2015-2020)
Table 8. Global Long-acting Injectable Medications Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Long-acting Injectable Medications Market Share by Regions (2021-2026)
Table 10. Long-acting Injectable Medications Market Market Trends
Table 11. Long-acting Injectable Medications Market Drivers
Table 12. Long-acting Injectable Medications Market Challenges
Table 13. Long-acting Injectable Medications Market Restraints
Table 14. Global Long-acting Injectable Medications Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Long-acting Injectable Medications Market Share by Players (2015-2020)
Table 16. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2019)
Table 17. Global Long-acting Injectable Medications by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Long-acting Injectable Medications Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Long-acting Injectable Medications Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Long-acting Injectable Medications Revenue Market Share by Type (2015-2020)
Table 23. Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Long-acting Injectable Medications Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Long-acting Injectable Medications Revenue Market Share by Application (2015-2020)
Table 26. Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Long-acting Injectable Medications Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Long-acting Injectable Medications Market Share by Type (2015-2020)
Table 29. North America Long-acting Injectable Medications Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Long-acting Injectable Medications Market Share by Application (2015-2020)
Table 31. North America Long-acting Injectable Medications Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Long-acting Injectable Medications Market Share by Country (2015-2020)
Table 33. Europe Long-acting Injectable Medications Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Long-acting Injectable Medications Market Share by Type (2015-2020)
Table 35. Europe Long-acting Injectable Medications Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Long-acting Injectable Medications Market Share by Application (2015-2020)
Table 37. Europe Long-acting Injectable Medications Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Long-acting Injectable Medications Market Share by Country (2015-2020)
Table 39. Asia-Pacific Long-acting Injectable Medications Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Long-acting Injectable Medications Market Share by Type (2015-2020)
Table 41. Asia-Pacific Long-acting Injectable Medications Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Long-acting Injectable Medications Market Share by Application (2015-2020)
Table 43. Asia-Pacific Long-acting Injectable Medications Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2015-2020)
Table 45. Latin America Long-acting Injectable Medications Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Long-acting Injectable Medications Market Share by Type (2015-2020)
Table 47. Latin America Long-acting Injectable Medications Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Long-acting Injectable Medications Market Share by Application (2015-2020)
Table 49. Latin America Long-acting Injectable Medications Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Long-acting Injectable Medications Market Share by Country (2015-2020)
Table 51. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Long-acting Injectable Medications Market Share by Type (2015-2020)
Table 53. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Long-acting Injectable Medications Market Share by Application (2015-2020)
Table 55. Middle East & Africa Long-acting Injectable Medications Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Long-acting Injectable Medications Market Share by Country (2015-2020)
Table 57. Eli Lilly Company Details
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Long-acting Injectable Medications Product
Table 60. Eli Lilly Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 61. Eli Lilly Recent Development
Table 62. Alkermes Company Details
Table 63. Alkermes Business Overview
Table 64. Alkermes Long-acting Injectable Medications Product
Table 65. Alkermes Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 66. Alkermes Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Long-acting Injectable Medications Product
Table 70. Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Zogenix Company Details
Table 73. Zogenix Business Overview
Table 74. Zogenix Long-acting Injectable Medications Product
Table 75. Zogenix Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 76. Zogenix Recent Development
Table 77. DURECT Company Details
Table 78. DURECT Business Overview
Table 79. DURECT Long-acting Injectable Medications Product
Table 80. DURECT Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 81. DURECT Recent Development
Table 82. Mapi Pharma Company Details
Table 83. Mapi Pharma Business Overview
Table 84. Mapi Pharma Long-acting Injectable Medications Product
Table 85. Mapi Pharma Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 86. Mapi Pharma Recent Development
Table 87. GSK Company Details
Table 88. GSK Business Overview
Table 89. GSK Long-acting Injectable Medications Product
Table 90. GSK Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 91. GSK Recent Development
Table 92. MedinCell Business Overview
Table 93. MedinCell Long-acting Injectable Medications Product
Table 94. MedinCell Company Details
Table 95. MedinCell Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 96. MedinCell Recent Development
Table 97. Oakwood Labs Company Details
Table 98. Oakwood Labs Business Overview
Table 99. Oakwood Labs Long-acting Injectable Medications Product
Table 100. Oakwood Labs Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 101. Oakwood Labs Recent Development
Table 102. Nanomi Company Details
Table 103. Nanomi Business Overview
Table 104. Nanomi Long-acting Injectable Medications Product
Table 105. Nanomi Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 106. Nanomi Recent Development
Table 107. Pharmathen Company Details
Table 108. Pharmathen Business Overview
Table 109. Pharmathen Long-acting Injectable Medications Product
Table 110. Pharmathen Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 111. Pharmathen Recent Development
Table 112. Kashiv BioSciences Company Details
Table 113. Kashiv BioSciences Business Overview
Table 114. Kashiv BioSciences Long-acting Injectable Medications Product
Table 115. Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2015-2020) (US$ Million)
Table 116. Kashiv BioSciences Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-acting Injectable Medications Market Share by Type: 2020 VS 2026
Figure 2. First-generation Features
Figure 3. Second-generation Features
Figure 4. Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2026
Figure 5. Schizophrenia Case Studies
Figure 6. Contraception Case Studies
Figure 7. HIV Case Studies
Figure 8. Others Case Studies
Figure 9. Long-acting Injectable Medications Report Years Considered
Figure 10. Global Long-acting Injectable Medications Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Long-acting Injectable Medications Market Share by Regions: 2020 VS 2026
Figure 12. Global Long-acting Injectable Medications Market Share by Regions (2021-2026)
Figure 13. Global Long-acting Injectable Medications Market Share by Players in 2019
Figure 14. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Long-acting Injectable Medications Revenue in 2019
Figure 16. North America Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Long-acting Injectable Medications Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Eli Lilly Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 42. Alkermes Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 43. Johnson & Johnson Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 44. Zogenix Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 45. DURECT Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 46. Mapi Pharma Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 47. GSK Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 48. MedinCell Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 49. Oakwood Labs Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 50. Nanomi Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 51. Pharmathen Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 52. Kashiv BioSciences Revenue Growth Rate in Long-acting Injectable Medications Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
長期介護（LTC）の世界市場（～2026年） Long-term care involves a variety of services designed to meet a person's health or personal care needs during a short or long period of time. The hospice care is the fastest growing market owing to the increasing incidence rates of Alzheimer’s and dementia and an increase in the post-hospital care.…- 注射可能ドラッグデリバリー製剤の世界市場（～2026年） Market Analysis and Insights: Global Injectable Drug Delivery Formulation Market The global Injectable Drug Delivery Formulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Injectable Drug Delivery Formulation Scop…
- スチールロング製品の世界市場（～2026年） In steel industry terminology long steel products or long products refers to steel products including wire, rod, rail, and bars as well as types of steel structural sections and girders. One trend in market is increase in use of steel scrap. The use of scraped steel and iron is increasing to reduce …
- プロポフォール中鎖・長鎖脂肪エマルジョン注射の世界市場（～2026年） Market Analysis and Insights: Global Propofol Medium and Long Chain Fat Emulsion Injection Market The global Propofol Medium and Long Chain Fat Emulsion Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Propofo…
- 長炭素繊維熱可塑性プラスチックの世界市場（～2026年） Market Analysis and Insights: Global Long Carbon Fiber Thermoplastic Market The global Long Carbon Fiber Thermoplastic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Long Carbon Fiber Thermoplastic Scope and Market Si…